These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3621170)
1. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Hedley DW; Rugg CA; Gelber RD Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170 [TBL] [Abstract][Full Text] [Related]
2. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789 [TBL] [Abstract][Full Text] [Related]
3. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer]. Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis. Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of flow cytometry for metastatic potential in breast cancer. Schmidt H; Wei JP; Yeh KA Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group. Bergers E; van Diest PJ; Baak JP Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093 [TBL] [Abstract][Full Text] [Related]
8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041 [TBL] [Abstract][Full Text] [Related]
9. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982 [TBL] [Abstract][Full Text] [Related]
11. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer. Velanovich V Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752 [TBL] [Abstract][Full Text] [Related]
12. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Hedley DW; Rugg CA; Ng AB; Taylor IW Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193 [TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and survival in breast cancer patients. Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068 [TBL] [Abstract][Full Text] [Related]
14. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341 [TBL] [Abstract][Full Text] [Related]
15. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Friedman NS; Freedman MD Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198 [TBL] [Abstract][Full Text] [Related]
16. Influence of cellular DNA content on survival in ovarian carcinoma. Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056 [TBL] [Abstract][Full Text] [Related]
17. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DNA ploidy in breast cancer stage I-II. Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293 [TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696 [TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]